查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1927375

周邊旋轉動脈粥狀硬化斑塊切除術市場按產品類型、索賠類型、應用和最終用戶分類 - 全球預測 2026-2032 年

Peripheral Rotational Atherectomy Market by Product Type, Claim Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年外周旋轉動脈動脈粥狀硬化斑塊切除術市場價值為 9.8568 億美元，預計到 2026 年將成長至 10.5878 億美元，年複合成長率為 8.28%，到 2032 年將達到 17.2068 億美元。

關鍵市場統計數據
基準年 2025 9.8568億美元
預計年份：2026年 1,058,780,000 美元
預測年份 2032 17.2068億美元
複合年成長率 (%) 8.28%

周邊動脈粥狀硬化斑塊切除術的臨床需求、技術成熟度、手術流程和相關人員動機概述

周邊旋轉動脈粥狀硬化斑塊切除術是一種針對鈣化性周邊動脈疾病的介入治療技術，其當代意義在於臨床、技術和操作因素的交會點。臨床醫師日益面臨膝下和髂股動脈區域複雜病變形態的挑戰，促使人們重新關注能夠在修復鈣化斑塊的同時，保留遠端灌注和肢體挽救潛力的工具。同時，器械的成熟也拓展了臨床醫生的選擇範圍，並推動了手術流程的改進，使其能夠整合混合策略、輔助影像學檢查以及高風險患者的分期重組。

臨床路徑、器材創新、報銷理念和競爭動態的變革性轉變重塑了周邊動脈粥狀硬化斑塊切除術

周邊血管動脈粥狀硬化斑塊切除術的格局正因多項變革而重塑，這些變革融合了臨床洞見、器械創新和醫保支付方的期望。在手術操作方面，輔助影像技術和血管準備策略的整合已取得顯著進展，從而降低了手術操作的變異性，並改善了病變特異性治療方案的發展。這種轉變提升了那些能夠實現可預測的斑塊修飾、最大限度減少下游栓塞，並針對不同病變形態提供獨特效用的器械的價值。

2025年美國關稅調整對供應鏈、設備成本、籌資策略及全球採購的累積影響

美國關稅調整將於2025年生效，其累積影響正為全球周邊介入器材供應鏈帶來新的複雜性，並影響採購、成本結構和籌資策略。擁有跨境業務的製造商和經銷商被迫重新評估其零件採購、合約條款和庫存管理政策，以緩解不斷增加的成本壓力。為此，一些供應商正在加快對替代供應商的資格認證，推廣本地組裝，並調整產品組合，以在保持臨床性能標準的同時，維持價格競爭力。

透過整合產品類型、臨床應用、終端使用者畫像和支付方理賠類別等因素進行高價值細分分析，指南策略定位

細緻的細分方法揭示了產品差異、臨床適應症、臨床環境和支付方路徑如何相互作用，從而決定周邊動脈粥狀硬化斑塊切除術的應用特徵和價值概況。產品細分區分了動脈粥狀硬化斑塊切除術導管（進一步分為高剖面導管和Low profile導管）和動脈粥狀硬化斑塊切除術系統（包括主機和可攜式系統）。這種區分會影響操作者的偏好、庫存計劃以及根據病變類型進行的臨床應用。應用細分區分了針對脛動脈和腓動脈的膝下介入治療以及髂股動脈介入治療。每種臨床環境都有其獨特的入路、影像和輔助性治療的考慮因素，這些因素都會影響器械的選擇。

影響臨床應用的區域趨勢和採用模式（美洲、歐洲、中東和非洲、亞太地區）

區域趨勢在決定周邊血管動脈粥狀硬化斑塊切除術的進入、應用和商業策略方面發揮關鍵作用。在美洲，報銷框架和一體化的醫療保健系統通常能夠促進協調的治療路徑開發，從而在臨床獲益得到證實的情況下支持技術的應用；同時，成本控制的壓力也要求提供明確的療效改善證據。在歐洲、中東和非洲，不同的管理體制和不均衡的支付結構使得制定量身定做的市場參與策略成為必要。製造商和臨床領導者通常依靠區域卓越中心和本地證據來支持技術的廣泛應用。在亞太地區，公私合作的資金籌措模式，加上介入治療服務能力的快速發展，既帶來了機遇，也帶來了競爭，尤其是在那些周邊血管計畫和肢體挽救舉措投資不斷增加的地區。

競爭與合作並存的企業趨勢：主要企業的產品系列與策略措施塑造了其競爭優勢

關鍵的企業趨勢正在塑造外周旋動脈粥狀硬化斑塊切除術的競爭定位和創新路線。器械製造商與臨床網路之間的策略聯盟加速了實證醫學證據的積累，並透過整合培訓、上市後監測和療效基準，為更廣泛的應用鋪平了道路。同時，有針對性的收購和產品組合重組使一些公司能夠透過將器械平台與止血、成像和導管技術相結合，從而提升臨床療效，進而拓展其價值提案。

針對醫療設備製造商、臨床領導者和支付者的具體建議：加速臨床應用、最佳化供應鏈韌性、改善病患預後

產業領導者應優先採取一系列協作行動，將洞見轉化為臨床和商業性績效的可衡量改善。首先，製造商和醫院合作夥伴需要投資於有針對性的臨床醫生教育和操作指導，以減少操作者之間的差異，並加速在各種病變類型中安全、一致地應用相關技術。此外，制定共用的通訊協定和結果指標，可以使手術團隊、護理人員和管理人員圍繞通用的品質目標達成一致，並更清晰地評估器械對併發症發生率和住院時間的影響。

全面透明的調查方法詳細說明了資料來源、相關人員參與、分析框架和檢驗方法。

本分析基於多源調查方法，旨在確保透明度、可重複性和對臨床及商業決策者的相關性。主要資料來源包括對介入醫師、器材採購人員和支付方代表的結構化訪談，以收集第一線經驗和關鍵採購挑戰。二級資訊來源包括同儕審查的臨床文獻、監管申報文件和操作指南文件，以檢驗臨床表現特徵和安全性概況。數據綜合根據一個主題框架進行，該框架將臨床適應症、醫療設備特性和操作限制聯繫起來。

為相關相關人員提供一份簡明扼要、重點突出的策略意義、臨床優先事項和後續操作步驟概述。

總之，周邊血管動脈粥狀硬化斑塊切除術的策略意義不僅限於器械選擇，還涵蓋臨床路徑設計、供應鏈韌性以及多方相關人員的協作。相關人員僅關注器械性能而忽略培訓、報銷和庫存動態等問題，則可能導致推廣速度緩慢，療效欠佳。相反，對臨床醫師教育、實證醫學證據產生和適應性採購模式進行協調投資，既能加快推廣速度，又能保障臨床品質和財務責任。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 周邊旋轉動脈動脈粥狀硬化斑塊切除術市場（依產品類型分類）

  • 旋切動脈粥狀硬化斑塊切除術
    • 高位導尿管
    • Low profile導管
  • 旋轉動脈粥狀動脈粥狀硬化斑塊切除術系統
    • 主機系統
    • 可攜式系統

9. 依索賠類型分類的周邊旋轉動脈粥狀硬化斑塊切除術市場

  • 政府保險
    • 醫療補助
    • 聯邦醫療保險
  • 自費
  • 私人保險
    • HMO
    • 產物保險
    • PPO

第10章 依應用分類的周邊旋轉動脈動脈粥狀硬化斑塊切除術市場

  • 膝蓋以下
    • 腓動脈
    • 脛骨
  • 髂股動脈

第11章 外周旋轉動脈粥樣斑塊動脈粥狀硬化斑塊切除術市場（按最終用戶分類）

  • 門診手術中心
    • 獨立中心
    • 醫院所屬中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所

12. 周邊旋轉動脈粥狀斑塊動脈粥狀硬化斑塊切除術市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 周邊旋轉動脈粥狀斑塊動脈粥狀硬化斑塊切除術市場（按組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國周邊血管旋轉動脈粥狀斑塊動脈粥狀硬化斑塊切除術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國周邊血管旋轉動脈動脈粥狀硬化斑塊切除術市場

第16章 中國周邊血管旋轉動脈粥狀斑塊動脈粥狀硬化斑塊切除術市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Avinger, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc
  • Cook Medical LLC
  • INVAMED
  • Koninklijke Philips NV
  • Medtronic PLC
  • NEScientific, Inc
  • NIPRO CORPORATION
  • RA Medical Systems, Inc.
  • Rotarex, SA by Becton, Dickinson and Company
  • Straub Medical AG
Product Code: MRR-4F7A6D4FF383

The Peripheral Rotational Atherectomy Market was valued at USD 985.68 million in 2025 and is projected to grow to USD 1,058.78 million in 2026, with a CAGR of 8.28%, reaching USD 1,720.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 985.68 million
Estimated Year [2026] USD 1,058.78 million
Forecast Year [2032] USD 1,720.68 million
CAGR (%) 8.28%

Introductory framing of clinical need technology maturation procedural workflows and stakeholder motivations that define peripheral rotational atherectomy

Peripheral rotational atherectomy represents a focused interventional capability for treating calcified peripheral arterial disease, and its contemporary relevance rests on intersecting clinical, technological, and operational drivers. Clinicians increasingly confront complex lesion morphology in below-knee and iliofemoral territories, prompting renewed attention to tools that can modify calcified plaque while preserving distal perfusion and limb salvage potential. Concurrently, device maturation has expanded options for practitioners, with procedural workflows evolving to incorporate hybrid strategies, adjunctive imaging, and staged revascularization in higher-risk patients.

From an operational perspective, institutions and ambulatory care sites are balancing the imperative to reduce length-of-stay and procedural complications against the need to maintain high-quality outcomes. As a result, clinical teams and procurement leaders are revisiting vendor selection criteria, lifecycle costs, and training commitments to ensure that adoption of ablative technologies translates into measurable improvements in patient throughput and complication avoidance. Taken together, these forces create a context in which strategic choices about product selection, pathway integration, and stakeholder alignment determine whether peripheral rotational atherectomy achieves durable adoption in contemporary practice.

Transformational shifts in clinical pathways device innovation reimbursement ethos and competitive dynamics reshaping peripheral rotational atherectomy

The landscape for peripheral rotational atherectomy is being reshaped by several transformative shifts that combine clinical insights, device innovation, and payer expectations. Procedurally, there is a visible movement toward integrating adjunctive imaging and vessel preparation strategies that reduce procedural variability and improve lesion-specific planning. This shift amplifies the value of devices that offer predictable plaque modification with minimal downstream embolization and clear utility across a range of lesion morphologies.

On the technology front, incremental improvements in catheter profiles, burr design, and system ergonomics are enabling broader operator comfort and more consistent performance in challenging anatomies. At the same time, the competitive environment has driven manufacturers to emphasize service models, training programs, and bundled offerings that align commercial terms with value-based outcomes. Reimbursement landscapes and hospital procurement priorities are also evolving; decision-makers increasingly require evidence linking device choice to reduced complications and downstream resource utilization. Together, these trends are converging to push peripheral rotational atherectomy from a niche specialty technique toward a more standardized component of complex limb salvage pathways, provided stakeholders coordinate training, supply, and clinical governance effectively.

Cumulative implications of United States tariff adjustments effective in 2025 on supply chains device costs procurement strategies and global sourcing

The cumulative impact of United States tariff adjustments implemented in 2025 has introduced new complexities to global supply chains for peripheral interventional devices, affecting procurement, cost structures, and sourcing strategies. Manufacturers and distributors operating across borders have had to re-evaluate component sourcing, contract terms, and inventory policies to mitigate incremental cost pressures. In response, some suppliers have accelerated qualification of alternative suppliers, localized assembly, or adjusted product configurations to preserve price competitiveness while maintaining clinical performance standards.

Procurement teams and hospital systems have likewise adapted purchasing strategies to respond to higher landed costs and greater supply volatility. Longer-term supply agreements, strategic inventory buffering, and closer collaboration with manufacturers on consignment or managed inventory models have emerged as pragmatic responses. Importantly, clinical teams and device leadership have emphasized the need to avoid compromising clinical choice; thus, value discussions have shifted from unit price alone to total cost of care, including procedure efficiency, complication avoidance, and readmission prevention. Looking forward, the tariff-driven pressures have catalyzed stronger cross-functional alignment among sourcing, clinical, and commercial teams to preserve access to essential technologies while managing fiscal accountability.

High-value segmentation insights integrating product types clinical applications end-user profiles and payer claim categories to inform strategic positioning

A nuanced segmentation approach reveals how product variants, clinical indications, care settings, and payer pathways interact to define distinct adoption and value profiles for peripheral rotational atherectomy. Product segmentation differentiates Rotational Atherectomy Catheters, which are further characterized by High Profile Catheters and Low Profile Catheters, from Rotational Atherectomy Systems, which comprise Console Systems and Portable Systems; this delineation affects operator preference, inventory planning, and clinical application across lesion types. Application segmentation distinguishes Below Knee interventions-including targeted Peroneal and Tibial procedures-from Iliofemoral interventions, with each clinical context presenting unique access, imaging, and adjunctive therapy considerations that influence device selection.

End-user segmentation captures the operational diversity of Ambulatory Surgery Centers, Hospitals, and Specialized Clinics. Ambulatory Surgery Centers are subdivided into Free Standing Centers and Hospital Owned Centers, while Hospitals are classified into Private Hospitals and Public Hospitals; these distinctions shape procurement cycles, training investments, and volume-driven economics. Finally, claim type segmentation illustrates how reimbursement pathways affect adoption, contrasting Government Insurance, broken down into Medicaid and Medicare, with Private Insurance arrangements including HMO, Indemnity Insurance, and PPO, and the role of Out Of Pocket payment. Together, these interlocking segments provide a framework for prioritizing clinical evidence generation, tailoring commercial propositions, and designing differentiated service models that align with the operational realities of each stakeholder group.

Region-specific dynamics and adoption patterns across the Americas Europe Middle East & Africa and Asia-Pacific that influence clinical access

Regional dynamics play an outsized role in determining access, uptake, and commercial strategy for peripheral rotational atherectomy. In the Americas, reimbursement frameworks and integrated health systems often enable coordinated pathway development that supports technology adoption when clinical benefit is demonstrable, but cost containment pressures demand clear evidence of improved outcomes. In Europe, Middle East & Africa, diverse regulatory regimes and heterogeneous payer architectures require tailored entry strategies; manufacturers and clinical champions often rely on regional centers of excellence and localized evidence to support broader adoption. In Asia-Pacific, mixed public-private funding models combine with rapid capacity expansion in interventional services to create both opportunities and competition, particularly where investments in peripheral vascular programs and limb salvage initiatives are expanding.

These geographic differences influence regulatory timelines, required evidence packages, and the structure of commercial partnerships. For example, product configurations and training programs that succeed in high-volume tertiary centers in one region may require adaptation for ambulatory or community-based settings elsewhere. Consequently, cross-regional learning and adaptive commercialization-where insights from one geography inform clinical education and value articulation in another-become important mechanisms to accelerate appropriate, sustainable adoption while respecting local reimbursement and regulatory realities.

Competitive and collaborative corporate developments product portfolios and strategic moves by key companies shaping competitive advantage

Key corporate developments are shaping competitive positioning and the innovation pipeline for peripheral rotational atherectomy. Strategic collaborations between device manufacturers and clinical networks have accelerated evidence generation and created pathways for broader adoption by aligning training, post-market surveillance, and outcome benchmarking. At the same time, targeted acquisitions and portfolio realignments have enabled some firms to extend their value propositions by combining device platforms with hemostasis, imaging, or catheter technologies that augment clinical efficacy.

Product portfolio strategies now emphasize not only device performance but also service elements such as training, proctoring, and data-driven outcome support. Companies that invest in clinician education, robust clinical registries, and integrated consignment or inventory solutions tend to see stronger alignment with hospital procurement committees. Moreover, firms that can demonstrate iterative product improvements while maintaining supply reliability and competitive commercial structures secure preferential consideration among health systems. Ultimately, competitive advantage is increasingly derived from the ability to offer a holistic solution that pairs device efficacy with operational support, clinical validation, and flexible contracting models.

Actionable recommendations for device manufacturers clinical leaders and payers to accelerate clinical adoption optimize supply resilience and improve patient

Industry leaders should prioritize a set of coordinated actions to translate insights into measurable improvements in clinical and commercial performance. First, manufacturers and hospital partners must invest in targeted clinician education and procedural proctoring to reduce operator variability and accelerate safe, consistent adoption across diverse lesion types. Complementary to this, creating shared protocols and outcome metrics can align surgical teams, nursing staff, and administrators around common quality goals, enabling clearer evaluation of device impact on complication rates and lengths of stay.

Second, supply resilience must be strengthened through diversified sourcing, strategic inventory policies, and collaborative commercial models such as consignment or vendor-managed inventory. These approaches mitigate near-term disruption while preserving clinician access to preferred device configurations. Third, payers and procurement teams should be engaged early with robust clinical evidence that links device selection to downstream cost avoidance and improved limb salvage; value-based contracting pilots can provide practical proof points. Finally, organizations should adopt iterative post-market surveillance and real-world evidence collection to inform iterative product improvements, support reimbursement dialogues, and sustain clinician confidence. Taken together, these actions create a pragmatic roadmap for stakeholders seeking to expand access while safeguarding quality and fiscal stewardship.

Comprehensive and transparent research methodology detailing data sources stakeholder engagements analytical frameworks and validation approaches

This analysis is grounded in a multi-source methodology designed to ensure transparency, reproducibility, and relevance to clinical and commercial decision-makers. Primary inputs included structured interviews with interventional specialists, device procurement leads, and payer representatives to capture frontline experiences and procurement imperatives. Secondary sources comprised peer-reviewed clinical literature, regulatory filings, and procedural guidance documents to verify clinical performance characteristics and safety profiles. Data synthesis followed a thematic framework that aligned clinical indications, device attributes, and operational constraints.

Analytical methods combined qualitative synthesis with cross-validation techniques to ensure that assertions about clinical utility, adoption barriers, and supply chain dynamics were corroborated across multiple sources. Validation approaches included expert review panels and scenario testing with clinician partners to ensure practical applicability. Where gaps in evidence were identified, the research prioritized triangulation through additional interviews and focused literature review. The result is a methodology that balances rigour with field relevance, producing insights that are actionable for product strategy, clinical engagement, and supply chain planning.

Concise but conclusive closing synthesis of strategic implications clinical priorities and operational next steps for stakeholders engaged

In closing, the strategic implications of peripheral rotational atherectomy extend beyond device selection to encompass clinical pathway design, supply chain resilience, and multi-stakeholder alignment. Stakeholders that focus solely on device performance without addressing training, reimbursement, and inventory dynamics risk slower adoption and suboptimal outcomes. Conversely, coordinated investments in clinician education, evidence generation, and adaptive procurement models can accelerate adoption while protecting clinical quality and fiscal responsibility.

Operationally, the path forward emphasizes cross-functional governance that unites clinical champions, procurement leaders, and payer relations teams. Clinically, sustained focus on outcome measurement and iterative practice improvement will be essential to demonstrate value. Taken together, these priorities form a pragmatic blueprint for institutions and manufacturers committed to expanding access to advanced peripheral interventions while ensuring that adoption translates into improved patient-centered outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Rotational Atherectomy Market, by Product Type

  • 8.1. Rotational Atherectomy Catheters
    • 8.1.1. High Profile Catheters
    • 8.1.2. Low Profile Catheters
  • 8.2. Rotational Atherectomy Systems
    • 8.2.1. Console Systems
    • 8.2.2. Portable Systems

9. Peripheral Rotational Atherectomy Market, by Claim Type

  • 9.1. Government Insurance
    • 9.1.1. Medicaid
    • 9.1.2. Medicare
  • 9.2. Out Of Pocket
  • 9.3. Private Insurance
    • 9.3.1. Hmo
    • 9.3.2. Indemnity Insurance
    • 9.3.3. Ppo

10. Peripheral Rotational Atherectomy Market, by Application

  • 10.1. Below Knee
    • 10.1.1. Peroneal
    • 10.1.2. Tibial
  • 10.2. Iliofemoral

11. Peripheral Rotational Atherectomy Market, by End User

  • 11.1. Ambulatory Surgery Centers
    • 11.1.1. Free Standing Centers
    • 11.1.2. Hospital Owned Centers
  • 11.2. Hospitals
    • 11.2.1. Private Hospitals
    • 11.2.2. Public Hospitals
  • 11.3. Specialized Clinics

12. Peripheral Rotational Atherectomy Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peripheral Rotational Atherectomy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peripheral Rotational Atherectomy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peripheral Rotational Atherectomy Market

16. China Peripheral Rotational Atherectomy Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Avinger, Inc.
  • 17.6. B. Braun SE
  • 17.7. Boston Scientific Corporation
  • 17.8. Cardiovascular Systems, Inc
  • 17.9. Cook Medical LLC
  • 17.10. INVAMED
  • 17.11. Koninklijke Philips N.V.
  • 17.12. Medtronic PLC
  • 17.13. NEScientific, Inc
  • 17.14. NIPRO CORPORATION
  • 17.15. RA Medical Systems, Inc.
  • 17.16. Rotarex, SA by Becton, Dickinson and Company
  • 17.17. Straub Medical AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HIGH PROFILE CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HIGH PROFILE CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HIGH PROFILE CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY LOW PROFILE CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY LOW PROFILE CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY LOW PROFILE CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CONSOLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CONSOLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CONSOLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICAID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICAID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICAID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDICARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY OUT OF POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY OUT OF POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY OUT OF POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDEMNITY INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDEMNITY INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDEMNITY INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PPO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PPO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PPO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PERONEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PERONEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PERONEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY TIBIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY TIBIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY TIBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ILIOFEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ILIOFEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ILIOFEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY FREE STANDING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY FREE STANDING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY FREE STANDING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SPECIALIZED CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SPECIALIZED CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 202. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 207. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 238. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 243. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 245. G7 PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 246. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ATHERECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY CLAIM TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY BELOW KNEE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA PERIPHERAL ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)